Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany Nong

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cells|August 28, 2024
Common Driver Mutations in AML: Biological Impact, Clinical Considerations, and Treatment StrategiesTiffany Nong, Shefali Mehra, Justin Taylor
Trends in Pharmacological Sciences|July 18, 2024
BTK inhibitors: past, present, and futureAllison Cool, Tiffany Nong, Skye Montoya, et al.
Future Science OA|September 3, 2025
ChatGPT's role in the rapidly evolving hematologic cancer landscapeTiffany Nong, Sean Britton, Viralkumar Bhanderi, et al.
Leukemia Research Reports|August 21, 2025
Intercurrent presentation of hairy cell leukemia and diffuse large B-cell lymphoma with hemophagocytic lymphohistiocytosis: a case reportTiffany Nong, Xiaoqiong Wang, Wenhui Li, et al.
Oral Oncology|September 13, 2022
Radiation induced taste changes in head and neck cancer - differential impact of treatment factorsTiffany Nong, Tammy Medrano, Cristina Marrero, et al.
Cureus|January 13, 2025
Cryptococcal Pneumonia in Multiple Myeloma: A Case ReportDustin Epstein, Joanna Herrera, Tiffany Nong, et al.
Advances in Radiation Oncology|June 15, 2026
Time Course and Determinants of Acute Dysgeusia in Patients Receiving Head and Neck Radiation TherapySreenija Yarlagadda, Arun Maharaj, Tiffany Nong, et al.
NPJ Precision Oncology|July 2, 2025
Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AMLJustin Watts, Tiffany Nong, Katarina Micin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cells|August 28, 2024
Common Driver Mutations in AML: Biological Impact, Clinical Considerations, and Treatment StrategiesTiffany Nong, Shefali Mehra, Justin Taylor
Trends in Pharmacological Sciences|July 18, 2024
BTK inhibitors: past, present, and futureAllison Cool, Tiffany Nong, Skye Montoya, et al.
Future Science OA|September 3, 2025
ChatGPT's role in the rapidly evolving hematologic cancer landscapeTiffany Nong, Sean Britton, Viralkumar Bhanderi, et al.
Leukemia Research Reports|August 21, 2025
Intercurrent presentation of hairy cell leukemia and diffuse large B-cell lymphoma with hemophagocytic lymphohistiocytosis: a case reportTiffany Nong, Xiaoqiong Wang, Wenhui Li, et al.
Oral Oncology|September 13, 2022
Radiation induced taste changes in head and neck cancer - differential impact of treatment factorsTiffany Nong, Tammy Medrano, Cristina Marrero, et al.
Cureus|January 13, 2025
Cryptococcal Pneumonia in Multiple Myeloma: A Case ReportDustin Epstein, Joanna Herrera, Tiffany Nong, et al.
Advances in Radiation Oncology|June 15, 2026
Time Course and Determinants of Acute Dysgeusia in Patients Receiving Head and Neck Radiation TherapySreenija Yarlagadda, Arun Maharaj, Tiffany Nong, et al.
NPJ Precision Oncology|July 2, 2025
Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AMLJustin Watts, Tiffany Nong, Katarina Micin, et al.
Pageof 1